Cite
N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells
MLA
Joshua A. Nord, et al. “N-Terminal BET Bromodomain Inhibitors Disrupt a BRD4-P65 Interaction and Reduce Inducible Nitric Oxide Synthase Transcription in Pancreatic β-Cells.” Frontiers in Endocrinology, vol. 13, Sept. 2022. EBSCOhost, https://doi.org/10.3389/fendo.2022.923925.
APA
Joshua A. Nord, Sarah L. Wynia-Smith, Alyssa L. Gehant, Rachel A. Jones Lipinski, Aaron Naatz, Inmaculada Rioja, Rab K. Prinjha, John A. Corbett, & Brian C. Smith. (2022). N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.923925
Chicago
Joshua A. Nord, Sarah L. Wynia-Smith, Alyssa L. Gehant, Rachel A. Jones Lipinski, Aaron Naatz, Inmaculada Rioja, Rab K. Prinjha, John A. Corbett, and Brian C. Smith. 2022. “N-Terminal BET Bromodomain Inhibitors Disrupt a BRD4-P65 Interaction and Reduce Inducible Nitric Oxide Synthase Transcription in Pancreatic β-Cells.” Frontiers in Endocrinology 13 (September). doi:10.3389/fendo.2022.923925.